Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil

Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Abstract

Vaccine adjuvants and vaccines may induce autoimmune and inflammatory manifestations in susceptible individuals. To date most human vaccine trials utilize aluminum (Al) adjuvants as placebos despite much evidence showing that Al in vaccine-relevant exposures can be toxic to humans and animals. We sought to evaluate the effects of Al adjuvant and the HPV vaccine Gardasil versus the true placebo on behavioral and inflammatory parameters in young female mice. Six week old C57BL/6 female mice were injected with either, Gardasil, Gardasil+pertussis toxin (Pt), Al hydroxide, or, vehicle control in amounts equivalent to human exposure. At six months of age, Gardasil and Al-injected mice spent significantly more time floating in the forced swimming test (FST) in comparison to vehicle-injected mice (Al, p=0.009; Gardasil, p=0.025; Gardasil+Pt, p=0.005). The increase in floating time was already highly significant at three months of age for the Gardasil and Gardasil+Pt group (p≤0.0001). No significant differences were observed in the number of stairs climbed in the staircase test nor in rotarod performance, both of which measure locomotor activity. Since rotarod also measures muscular strength, collectively these results indicate that differences observed in the FST were not due to locomotor dysfunction, but likely due to depression. Additionally, at three months of age, compared to control mice, Al-injected mice showed a significantly decreased preference for the new arm in the Y maze test (p=0.03), indicating short-term memory impairment. Moreover, anti-HPV antibodies from the sera of Gardasil and Gardasil+Pt-injected mice showed cross-reactivity with the mouse brain protein extract. Immunohistochemistry analysis revealed microglial activation in the CA1 area of the hippocampus of Gardasil-injected mice compared to the control. It appears that Gardasil via its Al adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes.

Links

Authors

 

Inbar R

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel; Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel.

Weiss R

Sagol School of Neuroscience, Tel Aviv University, Ramat Aviv, 69978 Tel-Aviv, Israel; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, 69978 Tel-Aviv, Israel.

Tomljenovic L

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel; Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, Canada V5Z 1L8.

Arango MT

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel; Doctoral Program in Biomedical Sciences, Universidad del Rosario, Bogota 111221, Colombia.

Deri Y

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel.

Shaw CA

Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, 828 W. 10th Ave, Vancouver, BC, Canada V5Z 1L8.

Chapman J

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel; Sagol School of Neuroscience, Tel Aviv University, Ramat Aviv, 69978 Tel-Aviv, Israel; Department of Neurology, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel.

Blank M

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel.

Shoenfeld Y

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel; Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, 69978 Tel-Aviv, Israel. Electronic address: shoenfel@post.tau.ac.il  .

 

Credit: www.unboundmedicine.com

Source

Vaccine : 2016 Jan 9 pg

Pub Type(s)

JOURNAL ARTICLE
 

Language

ENG

PubMed ID

26778424

Pro-Vax American Academy of Pediatrics Warns Parents About Dangerous HPV Vaccine

Teenage girl getting flu shot needle vaccination in arm

American College of Pediatricians Warning

The American College of Pediatricians has taken the extreme and possibly unprecedented step of releasing a disturbing statement (January 2016) outlining its legitimate concerns about the safety of the HPV vaccines Gardasil and Cervarix.

The purpose of the statement is so that “individuals considering the use of human papillomavirus vaccines could be made aware of these concerns pending further action by the regulatory agencies and manufacturers.”

The concern?

The connection between HPV vaccines Gardasil and Cervarix and premature ovarian failure (POF) in adolescent girls within weeks to several years of receiving these shots.

To its credit the American College of Pediatricians (ACPEDS) wants parents and physicians to know of of its concerns and is apparently not confident vaccine manufacturers or the FDA will do so adequately. The ACPEDS has identified these concerns as legitimate and ones that should be addressed immediately. Scott S. Field MD writing on behalf of the organization outlined the situation as follows (1):

(1) long-term ovarian function was not assessed in either the original rat safety studies or in the human HPV vaccine trials.

(2) most primary care physicians are probably unaware of a possible association between HPV4 and premature ovarian failure and may not consider reporting POF cases or prolonged amenorrhea (missing menstrual periods) to the Vaccine Adverse Event Reporting System (VAERS).

(3) potential mechanisms of action have been postulated based on autoimmune associations with the aluminum adjuvant used and previously documented ovarian toxicity in rats from another component, polysorbate 80.

(4) since licensure of Gardasil® in 2006, there have been about 213 VAERS reports (per the publicly available CDC WONDER VAERS database) involving amenorrhea, POF or premature menopause, 88% of which have been associated with Gardasil®. The two-strain HPV2, CervarixTM, was licensed late in 2009 and accounts for 4.7 % of VAERS amenorrhea reports since 2006, and 8.5% of those reports from February 2010 through May 2015. This compares to the pre-HPV vaccine period from 1990 to 2006 during which no cases of POF or premature menopause and 32 cases of amenorrhea were reported to VAERS.

 

Premature Ovarian Failure in Young Girls from Gardasil

Dr. Field writes that the cases of POF point alarmingly to Gardasil because the “overwhelming majority (76%) of VAERS reports since 2006 with ovarian failure, premature menopause, and/or amenorrhea are associated solely with Gardasil”.

Additionally, Dr. Field writes that “when VAERS reports since 2006 are restricted to cases in which amenorrhea (period stops) occurred for at least 4 months and is not associated with other known causes like polycystic ovary syndrome or pregnancy, 86/89 cases are associated with Gardasil, 3/89 with Cervarix, and 0/89 with other vaccines administered independently of an HPV vaccine”.

Is Polysorbate 80 the Toxic HPV Vaccine Ingredient Causing Premature Menopause in Girls?

You may want to sit down for this one. The ridiculously inadequate “safety trials” of Gardasil prior to its release actually used a placebo that contained the toxic ingredients polysorbate 80 as well as an aluminum based adjuvant.

Hence, these “safety studies” that were anything but never would have uncovered the alarming problem of POF prior to approval by the FDA to unleash this poison on our young girls.

Dr. Field writes about this jaw dropping oversight (or fraud?) by the vaccine manufacturers as follows:

Few other vaccines besides Gardasil® that are administered in adolescence contain polysorbate 80. Pre-licensure safety trials for Gardasil® used placebo that contained polysorbate 80 as well as aluminum adjuvant. Therefore, if such ingredients could cause ovarian dysfunction, an increase in amenorrhea probably would not have been detected in the placebo controlled trials. Furthermore, a large number of girls in the original trials were taking hormonal contraceptives which can mask ovarian dysfunction including amenorrhea and ovarian failure. Thus a causal relationship between human papillomavirus vaccines (if not Gardasil® specifically) and ovarian dysfunction cannot be ruled out at this time.

How could any self respecting scientist testing these vaccines knowingly use a placebo that actually contained some of the ingredients in the vaccine itself that was the subject of the clinical trial?  The placebo used should have been a simple saline placebo!

This is not science folks, this is science for sale. Worse, it is happening all the time.

Protect Your Daughters from the HPV Vaccines!

Due to the clear and obvious problems that not a single safety trial specifically addressed premature menopause and ovarian failure, the lack of use of saline placebos, and the majority of study participants in “safety trials” taking hormonal contraceptives which would have masked any problems indicates that there is no meaningful data to rule out a negative long term and permanent effect on ovarian function in women injected with Gardasil and Cervarix.

While a Vaccine Safety Datalink study to specifically research HPV vaccines and POF is planned, it will likely be many years before results will be determined. In addition, Dr. Field writes “Plus, POF within a few years of vaccination could be the tip of the iceberg since ovarian dysfunction manifested by months of amenorrhea may later progress to POF”.

To his credit, Dr. Field has contacted the maker of Gardasil, the Advisory Committee on Immunization Practices (ACIP), and the Food and Drug Administration (FDA) to make known the concerns of the American College of Pediatricians and request that:

  •  More rat studies be done to look at long-term ovarian function after HPV4 injections.
  •  The 89 VAERS reports identified with at least 4 months amenorrhea be reviewed by the CDC for further clarification since the publicly available WONDER VAERS database only contains initial reports.
  • Primary care providers be notified of a possible association between HPV and amenorrhea.

Predictably, the FDA has so far responded only with spin saying that they “will continue to conduct studies and monitor the safety of HPV vaccines. Should the weight of the evidence from VAERS or VSD and other sources indicate a likely causal association between POF and HPV vaccines, appropriate action will be taken in terms of communication and public health response.”

Translation?

If you want grandchildren, skip HPV vaccination with Gardasil or Cervarix for your daughter!

Sarah, The Healthy Home Economist

http://www.thehealthyhomeeconomist.com/american-college-of-pediatrians-warning-gardasil-hpv-vaccines/

Source and More Information

New Concerns about the Human Papillomavirus Vaccine, American College of Pediatricians, Dr. Scott Field, January 2016

Gardasil: Guarding or Gutting Our Youth? by Kelly Brogan MD

Gardasil causes Severe Genital Warts in 19 Year Old Virgin

Japan Withdraws Support of HPV Vaccines